MaxCyte (MXCT)
(Delayed Data from NSDQ)
$1.52 USD
-0.10 (-6.17%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.52 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MXCT 1.52 -0.10(-6.17%)
Will MXCT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MXCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MXCT
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
MXCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -27.78% in 4 Weeks, Here's Why You Should You Buy the Dip in MaxCyte (MXCT)
Down -30.2% in 4 Weeks, Here's Why MaxCyte (MXCT) Looks Ripe for a Turnaround
MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know
Other News for MXCT
Pocket Pivot appears for MXCT after 8.0% move
MXCT forms Directional Movement Crossover Bullish on September 17
MXCT forms Bollinger Band Squeeze on September 16
Is MXCT about to break its pattern? Bollinger Band Squeeze shows up after dropping 2.03%
MXCT forms 20 Day Moving Average Support on September 11